Cargando…
Maternal Immunization with a Single-Cycle Herpes Simplex Virus (HSV) Candidate Vaccine, ΔgD-2, Protects Neonatal Mice from Lethal Viral Challenge
BACKGROUND: Perinatal HSV is associated with ~60% mortality if untreated and with substantial morbidity even with appropriate therapy. We recently engineered a single-cycle virus deleted in glycoprotein-D (ΔgD-2) that induces high-titer antibodies (Abs) that are non-neutralizing but activate the Fc...
Autores principales: | Kao, Carol, Burn, Clare, Jacobs, William R, Herold, Betsy C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632254/ http://dx.doi.org/10.1093/ofid/ofx162.056 |
Ejemplares similares
-
Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
por: Mahant, Aakash Mahant, et al.
Publicado: (2023) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
por: Burn Aschner, Clare, et al.
Publicado: (2020) -
1410. Neonatal Herpes Simplex Virus (HSV) Infection: Is It the Only Pathogen?
por: Dendi, Alvaro, et al.
Publicado: (2020) -
Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
por: Burn Aschner, Clare, et al.
Publicado: (2020) -
1751. The Conundrum of Neonatal Herpes Simplex Virus (HSV) Disease: Co-infections do Happen!
por: Mejias, Asuncion, et al.
Publicado: (2023)